drugset / Trial / NCT02573922

Opioid Induced Bowel Dysfunction in Patients Undergoing Spinal Surgery

NCT02573922

Phase 4 Completed 180 enrolled Kuopio University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

In the present study, the primary aim was to evaluate if oxycodone-naloxone combination compared to oxycodone reduced opioid induced constipation in patients with or without chronic opioid treatment undergoing spine surgery.

Timeline

Start
2012-05
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxone Small molecule 5 mg
Subject Oxycodone Other / unclassified 10 mg

Indications